✦ LIBER ✦

Efficacy and safety of pegylated interferon plus ribavirin in patients with hepatitis C recurrence after liver transplantation: A single centre experience

✍ Scribed by M.F. Donato; F. Agnelli; M. Vigano’; C. Rigamonti; G. Rossi; M. Colombo

Book ID: 119228487
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 61 KB
Volume: 39
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2006.12.044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon plus ribavirin in H

Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

✍ Castells, Lluis; Rimola, Antoni; Manzardo, Christian; Valdivieso, Andrés; Monter 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 519 KB

767 Treatment of patients with recurrent

767 Treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon and ribavirin

✍ Didier Samuel; Paul Brousse 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Efficacy and safety of ribavirin plus pe

Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C

✍ Hu, C.-C.; Lin, C.-L.; Kuo, Y.-L.; Chien, C.-H.; Chen, S.-W.; Yen, C.-L.; Lin, C 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Clinical and histological efficacy of pe

Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation

✍ Inmaculada Fernández; Juan Carlos Meneu; Francisco Colina; Ignacio García; Raque 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Treatment of recurrent hepatitis C in liver transplant is controversial. The aim of our study was to evaluate the clinical and histological efficacy of pegylated interferon alpha 2b (PEG-IFN) and ribavirin therapy of recurrent hepatitis C after liver transplantation (LT). We prospectively included 4

Treatment of recurrent hepatitis C after

Treatment of recurrent hepatitis C after liver transplantation with pegylated interferon alfa-2b plus ribavirin. Preliminary analysis

✍ Ghalib, Reem H.; Levine, Cheryl D.; Stribling, Rise; McClelland, Tricia; Box, Te 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Commentary: efficacy and safety of ribav

Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C

✍ Hadziyannis, S. J.; Sevastianos, V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB